Karestar Technology (Xuzhou) Co., Ltd.

Karestar Technology Xuzhou Co., Ltd. Was established in 2015 and is a high-tech enterprise specializing in the research and development, production, and sales of medical devices in the fields of obstetrics and gynecology. Our product range covers a wide range of ultrasound machines, patient monitors, electrocardiogram machines, X-ray machines, laboratory equipment, and veterinary medical equipment.

Karestar has advanced automated production and testing equipment, and strictly adheres to the IOS13485 and ISO9001 standard production system. Meanwhile, our products have passed various certifications. Our professional R&D team, comprehensive sales system, and service philosophy have enabled our company′s products to have a high reputation and market share both domestically and internationally. It has been exported to over 60 countries in the Americas, Europe, Africa, Asia, and more.

The core philosophy of our company is "to build a brand as the goal, quality control as the initial intention, and customer first as the principle". We adhere to establishing long-term and stable friendly business relationships with customers around the world. Based on fairness, impartiality, and openness; Putting customer interests first and providing the best products and services to every customer; Satisfy customers with one-stop procurement and multiple solutions.

Our product has various qualification certifications, testing certificates, and the only full series of products in the country have product liability insurance. There are many repeat customers.

With just one authorization, you can enjoy the agency rights for dozens of high-quality products, helping you fully and fastly occupy the aim market.

Since corporation establish, strict price control has been implemented, pursuing fair competition while also safeguarding the rights and interests of agents at all levels.

2017-2019 Sign major strategic agreements with two domestic listed companies, and the color ultrasound series is launched.

2019 The company′s scientific research team developed a new product, electrocardiograph, and obtained a patent.

2020 Developed patient monitor and launched it.

2020-2022 Due to the severe global epidemic situation, the company transition to the network market to open up new sales concepts.

2022-2023 Sign authorization with distributors in Southeast Asia, the Middle East, and parts of Europe and the United States to act as the exclusive agent for the company′s products in the target

Market.